Diamante Closes Euro 595,000 Seed Round Led By Arieli Capital
01/17/23, 8:52 AM
Location
veronaIndustry
therapeutics
biotechnology
health care
Round Type
seed
Investors
Angels4 Women, Elena Paola Lanati, Diamante, Arieli Capital
Diamante S.r.l., a female-led Italian biotechnology company focused on the use of plants for producing high value-added molecules, closes Euro 595K as a second Seed Round led by Arieli Capital. Offering value for global markets, Diamante is creating a groundbreaking health technology with the power to improve the health of millions of people around the world.
Company Info
Location
verona, new jersey, united states
Additional Info
DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules.
The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications.
As an innovation-oriented female company, our value proposition is the creation of novel therapeutic approach for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides.
Diamante, thanks to the Regione Veneto and particularly though the national grant POR FESR AZIONE 1.1.1 2020/2021, has achieved important results in the diagnostic field for the Rheumatoid Arthritis (RA). This project allowed the company to increase the team with two more specialized people and to develop a specific technology platform for the RA diagnoses.